Antibody Engineering Promotes Nanomedicine for Cancer Treatment
Authors:
- 1 October 2010
- journal article
- Published by Taylor & Francis in Nanomedicine
- Vol. 5 (8) , 1141-1145
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- Lyophilized HER2-specific PEGylated immunoliposomes for active siRNA gene silencingBiomaterials, 2010
- Targeted drug delivery strategies to treat lung metastasisExpert Opinion on Drug Delivery, 2009
- Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancerCancer Immunology, Immunotherapy, 2008
- Treatment of hepatocellular carcinoma in mice with PE38KDEL type I mutant-loaded poly(lactic-co-glycolic acid) nanoparticles conjugated with humanized SM5-1 F(ab′) fragmentsMolecular Cancer Therapeutics, 2008
- PE38KDEL-loaded anti-HER2 nanoparticles inhibit breast tumor progression with reduced toxicity and immunogenicityBreast Cancer Research and Treatment, 2008
- Antibody constructs in cancer therapyCancer, 2007
- Antibody targeted drugs as cancer therapeuticsNature Reviews Drug Discovery, 2006
- Monoclonal antibody therapy of cancerNature Biotechnology, 2005
- Paul Ehrlich's Magic BulletsNew England Journal of Medicine, 2004
- Human Immune Respone to Monoclonal AntibodiesJournal of Immunotherapy, 1994